On 20 September, Lonza will host a free virtual workshop on using genome editing technologies for cell and gene therapies and drug discovery.
The 3-hour workshop brings together renowned genome editing experts from across industry and academia and comprises four interactive speaker sessions and a concluding panel discussion.
The event is a chance for researchers to engage directly with leading voices in the field, keep up to date with the latest CRISPR research and application.
Interest in cell and gene therapies is growing at pace, driven by their potential to address the rarest and most complex human diseases. CRISPR technology has revolutionised this sector, offering a simple, precise, and accurate gene-editing tool to expedite and scale discovery and development. Gathering a community of researchers that are at the forefront of the CRISPR revolution can help foster innovation, ultimately enabling more fruitful research and better patient treatments.
The event will bring together four internationally recognised experts in the field of genome editing, holding positions in respected global institutions such as the Berlin Centre for Advanced Therapies and Stanford University.
The speakers have made significant contributions to the field, including through creating new methods for high-throughput genetic engineering of primary human immune cells, and enhancing the intrinsic antitumor capacity of natural killer cells.
Speakers:
- Dimitrios Laurin Wagner, MD, PhD, Head of R&D at BeCAT, Charité - Universitätsmedizin Berlin, Germany
- Tobias Bexte, MD Student, Children’s Hospital, University Hospital Frankfurt am Main, Germany
- Theodore Roth, MD, PhD, Resident, Clinical Pathology, Stanford University, USA; Co-Founder, Arsenal Biosciences
- Benedetta Carbone, PhD, Scientific Investigator, GSK, Stevenage, UK
